nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—CYP4A11—Dexamethasone—atopic dermatitis	0.1	0.158	CbGbCtD
Cisplatin—SLC22A2—Diphenhydramine—atopic dermatitis	0.0775	0.122	CbGbCtD
Cisplatin—BCHE—Triamcinolone—atopic dermatitis	0.0563	0.0886	CbGbCtD
Cisplatin—PTGS2—Triamcinolone—atopic dermatitis	0.0433	0.0682	CbGbCtD
Cisplatin—CYP2B6—Diphenhydramine—atopic dermatitis	0.0402	0.0633	CbGbCtD
Cisplatin—PTGS2—Betamethasone—atopic dermatitis	0.0372	0.0585	CbGbCtD
Cisplatin—ABCG2—Hydrocortisone—atopic dermatitis	0.0318	0.05	CbGbCtD
Cisplatin—ABCB1—Tacrolimus—atopic dermatitis	0.0282	0.0443	CbGbCtD
Cisplatin—ABCC2—Dexamethasone—atopic dermatitis	0.0219	0.0344	CbGbCtD
Cisplatin—PTGS2—Dexamethasone—atopic dermatitis	0.0216	0.034	CbGbCtD
Cisplatin—CYP2C9—Loratadine—atopic dermatitis	0.0212	0.0334	CbGbCtD
Cisplatin—CYP2C9—Diphenhydramine—atopic dermatitis	0.0212	0.0334	CbGbCtD
Cisplatin—ABCB1—Loratadine—atopic dermatitis	0.0206	0.0324	CbGbCtD
Cisplatin—ABCG2—Dexamethasone—atopic dermatitis	0.0198	0.0311	CbGbCtD
Cisplatin—ABCB1—Methylprednisolone—atopic dermatitis	0.0189	0.0297	CbGbCtD
Cisplatin—ABCC6—dermis—atopic dermatitis	0.0167	0.295	CbGeAlD
Cisplatin—CYP2B6—Dexamethasone—atopic dermatitis	0.0139	0.0219	CbGbCtD
Cisplatin—ABCB1—Betamethasone—atopic dermatitis	0.0123	0.0193	CbGbCtD
Cisplatin—ABCB1—Prednisolone—atopic dermatitis	0.0121	0.019	CbGbCtD
Cisplatin—ABCB1—Hydrocortisone—atopic dermatitis	0.0115	0.018	CbGbCtD
Cisplatin—ABCB1—Prednisone—atopic dermatitis	0.0114	0.018	CbGbCtD
Cisplatin—CYP2C9—Dexamethasone—atopic dermatitis	0.00735	0.0116	CbGbCtD
Cisplatin—ABCB1—Dexamethasone—atopic dermatitis	0.00713	0.0112	CbGbCtD
Cisplatin—GSTT1—neck—atopic dermatitis	0.00415	0.0733	CbGeAlD
Cisplatin—GSTM1—neck—atopic dermatitis	0.00306	0.054	CbGeAlD
Cisplatin—MT2A—skin of body—atopic dermatitis	0.00274	0.0485	CbGeAlD
Cisplatin—NQO1—neck—atopic dermatitis	0.00214	0.0378	CbGeAlD
Cisplatin—GSTM1—skin of body—atopic dermatitis	0.00198	0.0349	CbGeAlD
Cisplatin—ATP7B—head—atopic dermatitis	0.00193	0.034	CbGeAlD
Cisplatin—GSTP1—neck—atopic dermatitis	0.00192	0.0338	CbGeAlD
Cisplatin—PTGS2—skin epidermis—atopic dermatitis	0.00187	0.0329	CbGeAlD
Cisplatin—MT2A—head—atopic dermatitis	0.00179	0.0316	CbGeAlD
Cisplatin—SLC31A2—head—atopic dermatitis	0.00176	0.0311	CbGeAlD
Cisplatin—GSTT1—head—atopic dermatitis	0.00175	0.0309	CbGeAlD
Cisplatin—ABCC6—head—atopic dermatitis	0.00142	0.0251	CbGeAlD
Cisplatin—NQO1—skin of body—atopic dermatitis	0.00139	0.0245	CbGeAlD
Cisplatin—SLC31A1—head—atopic dermatitis	0.00132	0.0234	CbGeAlD
Cisplatin—GSTM1—head—atopic dermatitis	0.00129	0.0228	CbGeAlD
Cisplatin—MPO—skin of body—atopic dermatitis	0.00128	0.0225	CbGeAlD
Cisplatin—GSTP1—skin of body—atopic dermatitis	0.00124	0.0219	CbGeAlD
Cisplatin—NQO1—head—atopic dermatitis	0.000905	0.016	CbGeAlD
Cisplatin—PTGS2—Fluocinonide—Desonide—atopic dermatitis	0.000858	0.165	CbGdCrCtD
Cisplatin—MPO—head—atopic dermatitis	0.000832	0.0147	CbGeAlD
Cisplatin—ABCC3—head—atopic dermatitis	0.000812	0.0143	CbGeAlD
Cisplatin—GSTP1—head—atopic dermatitis	0.000809	0.0143	CbGeAlD
Cisplatin—BCHE—skin of body—atopic dermatitis	0.00075	0.0132	CbGeAlD
Cisplatin—CYP2B6—skin of body—atopic dermatitis	0.000669	0.0118	CbGeAlD
Cisplatin—PTGS2—Fluocinonide—Fluocinolone Acetonide—atopic dermatitis	0.000668	0.128	CbGdCrCtD
Cisplatin—PTGS2—skin of body—atopic dermatitis	0.000578	0.0102	CbGeAlD
Cisplatin—PTGS2—Fluocinonide—Mometasone—atopic dermatitis	0.000533	0.102	CbGdCrCtD
Cisplatin—BCHE—head—atopic dermatitis	0.00049	0.00864	CbGeAlD
Cisplatin—CYP2B6—head—atopic dermatitis	0.000437	0.00771	CbGeAlD
Cisplatin—PTGS2—Fluticasone Propionate—Fluocinonide—atopic dermatitis	0.000415	0.0797	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	0.000403	0.0774	CbGdCrCtD
Cisplatin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000378	0.00622	CbGpPWpGaD
Cisplatin—PTGS2—head—atopic dermatitis	0.000377	0.00666	CbGeAlD
Cisplatin—MPO—IL23-mediated signaling events—CD4—atopic dermatitis	0.000374	0.00617	CbGpPWpGaD
Cisplatin—MT2A—AP-1 transcription factor network—IL2—atopic dermatitis	0.00037	0.0061	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CABIN1—atopic dermatitis	0.000366	0.00602	CbGpPWpGaD
Cisplatin—SOD1—AGE/RAGE pathway—NFKBIA—atopic dermatitis	0.000364	0.006	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—IL1B—atopic dermatitis	0.000346	0.00569	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—IL2—atopic dermatitis	0.000344	0.00567	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.000344	0.00566	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—CASP1—atopic dermatitis	0.000337	0.00555	CbGpPWpGaD
Cisplatin—SOD1—AGE/RAGE pathway—CASP8—atopic dermatitis	0.000329	0.00542	CbGpPWpGaD
Cisplatin—BCHE—Peptide hormone metabolism—CMA1—atopic dermatitis	0.000324	0.00533	CbGpPWpGaD
Cisplatin—PTGS2—Fluticasone Propionate—Mometasone—atopic dermatitis	0.000321	0.0618	CbGdCrCtD
Cisplatin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—atopic dermatitis	0.000321	0.00529	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL5—atopic dermatitis	0.00032	0.00526	CbGpPWpGaD
Cisplatin—PTGS2—Fluocinonide—Methylprednisolone—atopic dermatitis	0.000318	0.0612	CbGdCrCtD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.000317	0.00523	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—atopic dermatitis	0.000314	0.00518	CbGpPWpGaD
Cisplatin—PTGS2—Fluocinonide—Betamethasone—atopic dermatitis	0.000313	0.0602	CbGdCrCtD
Cisplatin—PTGS2—Fluocinonide—Dexamethasone—atopic dermatitis	0.000313	0.0602	CbGdCrCtD
Cisplatin—ABCC5—Carbohydrate metabolism—GLB1—atopic dermatitis	0.000311	0.00512	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.000306	0.00505	CbGpPWpGaD
Cisplatin—PTGS2—Fluocinonide—Triamcinolone—atopic dermatitis	0.000306	0.0588	CbGdCrCtD
Cisplatin—MPO—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.0003	0.00494	CbGpPWpGaD
Cisplatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000299	0.00493	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000288	0.00474	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	0.000283	0.00466	CbGpPWpGaD
Cisplatin—ATP7B—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000282	0.00465	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	0.000282	0.00464	CbGpPWpGaD
Cisplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TNF—atopic dermatitis	0.000281	0.00464	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—IFNG—atopic dermatitis	0.00028	0.00461	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.000267	0.00441	CbGpPWpGaD
Cisplatin—MT2A—Immune System—FCER1A—atopic dermatitis	0.000258	0.00425	CbGpPWpGaD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—atopic dermatitis	0.000253	0.00417	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—TNF—atopic dermatitis	0.000251	0.00413	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—IL1B—atopic dermatitis	0.000249	0.00411	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—IL2—atopic dermatitis	0.000248	0.00409	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.000247	0.00407	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—IFNG—atopic dermatitis	0.000244	0.00402	CbGpPWpGaD
Cisplatin—ATP7A—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00024	0.00395	CbGpPWpGaD
Cisplatin—MT2A—Immune System—MS4A2—atopic dermatitis	0.00024	0.00395	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL18—atopic dermatitis	0.000235	0.00386	CbGpPWpGaD
Cisplatin—ABCB1—head—atopic dermatitis	0.000233	0.00412	CbGeAlD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—atopic dermatitis	0.00023	0.00379	CbGpPWpGaD
Cisplatin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.00023	0.00379	CbGpPWpGaD
Cisplatin—ABCC6—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00023	0.00379	CbGpPWpGaD
Cisplatin—SLC31A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00023	0.00379	CbGpPWpGaD
Cisplatin—SOD1—AGE/RAGE pathway—MAPK8—atopic dermatitis	0.000229	0.00377	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—CD4—atopic dermatitis	0.000228	0.00376	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—TNF—atopic dermatitis	0.000222	0.00366	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000222	0.00366	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—IL1B—atopic dermatitis	0.000218	0.00358	CbGpPWpGaD
Cisplatin—MT2A—AP-1 transcription factor network—IL6—atopic dermatitis	0.000218	0.00358	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—IL2—atopic dermatitis	0.000217	0.00357	CbGpPWpGaD
Cisplatin—MT2A—Immune System—DEFB1—atopic dermatitis	0.000214	0.00352	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000212	0.00349	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—KIF3A—atopic dermatitis	0.000209	0.00344	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—IFNG—atopic dermatitis	0.000206	0.00339	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	0.000205	0.00338	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	0.000205	0.00338	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—IL6—atopic dermatitis	0.000202	0.00333	CbGpPWpGaD
Cisplatin—PTGS2—Overview of nanoparticle effects—CXCL8—atopic dermatitis	0.000199	0.00329	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000198	0.00326	CbGpPWpGaD
Cisplatin—Hypokalaemia—Prednisone—atopic dermatitis	0.000198	0.000817	CcSEcCtD
Cisplatin—Pain—Tacrolimus—atopic dermatitis	0.000197	0.000813	CcSEcCtD
Cisplatin—MPO—C-MYB transcription factor network—CD4—atopic dermatitis	0.000194	0.0032	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—TNF—atopic dermatitis	0.000194	0.0032	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000194	0.00319	CbGpPWpGaD
Cisplatin—Bradycardia—Triamcinolone—atopic dermatitis	0.000194	0.0008	CcSEcCtD
Cisplatin—Bradycardia—Methylprednisolone—atopic dermatitis	0.000193	0.000799	CcSEcCtD
Cisplatin—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000192	0.000796	CcSEcCtD
Cisplatin—PTGS2—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	0.000192	0.0369	CbGdCrCtD
Cisplatin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000191	0.00314	CbGpPWpGaD
Cisplatin—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000191	0.000789	CcSEcCtD
Cisplatin—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000191	0.000788	CcSEcCtD
Cisplatin—Feeling abnormal—Tacrolimus—atopic dermatitis	0.00019	0.000784	CcSEcCtD
Cisplatin—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000189	0.000783	CcSEcCtD
Cisplatin—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000189	0.000783	CcSEcCtD
Cisplatin—PTGS2—Fluticasone Propionate—Dexamethasone—atopic dermatitis	0.000189	0.0363	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Betamethasone—atopic dermatitis	0.000189	0.0363	CbGdCrCtD
Cisplatin—Eye disorder—Hydrocortisone—atopic dermatitis	0.000189	0.00078	CcSEcCtD
Cisplatin—Myocardial infarction—Betamethasone—atopic dermatitis	0.000188	0.000779	CcSEcCtD
Cisplatin—Myocardial infarction—Dexamethasone—atopic dermatitis	0.000188	0.000779	CcSEcCtD
Cisplatin—Neuropathy peripheral—Dexamethasone—atopic dermatitis	0.000188	0.000779	CcSEcCtD
Cisplatin—Neuropathy peripheral—Betamethasone—atopic dermatitis	0.000188	0.000779	CcSEcCtD
Cisplatin—Conjunctivitis—Betamethasone—atopic dermatitis	0.000187	0.000773	CcSEcCtD
Cisplatin—Conjunctivitis—Dexamethasone—atopic dermatitis	0.000187	0.000773	CcSEcCtD
Cisplatin—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000186	0.000771	CcSEcCtD
Cisplatin—Arrhythmia—Prednisolone—atopic dermatitis	0.000185	0.000764	CcSEcCtD
Cisplatin—PTGS2—Fluticasone Propionate—Triamcinolone—atopic dermatitis	0.000185	0.0355	CbGdCrCtD
Cisplatin—Pancreatitis—Prednisone—atopic dermatitis	0.000184	0.000761	CcSEcCtD
Cisplatin—Vomiting—Mometasone—atopic dermatitis	0.000184	0.00076	CcSEcCtD
Cisplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—atopic dermatitis	0.000183	0.00302	CbGpPWpGaD
Cisplatin—Sweating increased—Prednisone—atopic dermatitis	0.000183	0.000756	CcSEcCtD
Cisplatin—Visual impairment—Methylprednisolone—atopic dermatitis	0.000183	0.000756	CcSEcCtD
Cisplatin—Immune system disorder—Hydrocortisone—atopic dermatitis	0.000182	0.000754	CcSEcCtD
Cisplatin—Rash—Mometasone—atopic dermatitis	0.000182	0.000753	CcSEcCtD
Cisplatin—Dermatitis—Mometasone—atopic dermatitis	0.000182	0.000753	CcSEcCtD
Cisplatin—Body temperature increased—Tacrolimus—atopic dermatitis	0.000182	0.000752	CcSEcCtD
Cisplatin—SOD1—Folate Metabolism—TNF—atopic dermatitis	0.000181	0.00298	CbGpPWpGaD
Cisplatin—Arrhythmia—Hydrocortisone—atopic dermatitis	0.00018	0.000746	CcSEcCtD
Cisplatin—Erythema—Prednisolone—atopic dermatitis	0.00018	0.000744	CcSEcCtD
Cisplatin—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00018	0.000743	CcSEcCtD
Cisplatin—SOD1—Vitamin B12 Metabolism—IL6—atopic dermatitis	0.000179	0.00296	CbGpPWpGaD
Cisplatin—Eye disorder—Methylprednisolone—atopic dermatitis	0.000177	0.000733	CcSEcCtD
Cisplatin—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000176	0.000728	CcSEcCtD
Cisplatin—Malnutrition—Hydrocortisone—atopic dermatitis	0.000176	0.000727	CcSEcCtD
Cisplatin—Erythema—Hydrocortisone—atopic dermatitis	0.000176	0.000727	CcSEcCtD
Cisplatin—Bradycardia—Betamethasone—atopic dermatitis	0.000176	0.000726	CcSEcCtD
Cisplatin—Bradycardia—Dexamethasone—atopic dermatitis	0.000176	0.000726	CcSEcCtD
Cisplatin—CYP4A11—PPARA activates gene expression—PPARA—atopic dermatitis	0.000174	0.00286	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000173	0.00285	CbGpPWpGaD
Cisplatin—Nausea—Mometasone—atopic dermatitis	0.000172	0.00071	CcSEcCtD
Cisplatin—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000171	0.000709	CcSEcCtD
Cisplatin—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000171	0.000707	CcSEcCtD
Cisplatin—MT2A—Immune System—KIF3A—atopic dermatitis	0.000171	0.00281	CbGpPWpGaD
Cisplatin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	0.00017	0.0028	CbGpPWpGaD
Cisplatin—Arrhythmia—Triamcinolone—atopic dermatitis	0.00017	0.000702	CcSEcCtD
Cisplatin—Vision blurred—Prednisolone—atopic dermatitis	0.00017	0.000701	CcSEcCtD
Cisplatin—Arrhythmia—Methylprednisolone—atopic dermatitis	0.00017	0.000701	CcSEcCtD
Cisplatin—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000169	0.000701	CcSEcCtD
Cisplatin—XDH—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000169	0.00279	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—SELE—atopic dermatitis	0.000168	0.00277	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000168	0.00277	CbGpPWpGaD
Cisplatin—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000167	0.000691	CcSEcCtD
Cisplatin—Visual impairment—Dexamethasone—atopic dermatitis	0.000166	0.000688	CcSEcCtD
Cisplatin—Visual impairment—Betamethasone—atopic dermatitis	0.000166	0.000688	CcSEcCtD
Cisplatin—Erythema—Triamcinolone—atopic dermatitis	0.000166	0.000684	CcSEcCtD
Cisplatin—Erythema—Methylprednisolone—atopic dermatitis	0.000165	0.000683	CcSEcCtD
Cisplatin—Malnutrition—Methylprednisolone—atopic dermatitis	0.000165	0.000683	CcSEcCtD
Cisplatin—Asthenia—Tacrolimus—atopic dermatitis	0.000165	0.000682	CcSEcCtD
Cisplatin—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000165	0.000682	CcSEcCtD
Cisplatin—Neuropathy peripheral—Prednisone—atopic dermatitis	0.000164	0.000678	CcSEcCtD
Cisplatin—Myocardial infarction—Prednisone—atopic dermatitis	0.000164	0.000678	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—atopic dermatitis	0.000164	0.0027	CbGpPWpGaD
Cisplatin—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000163	0.000674	CcSEcCtD
Cisplatin—Malaise—Prednisolone—atopic dermatitis	0.000162	0.000671	CcSEcCtD
Cisplatin—Eye disorder—Dexamethasone—atopic dermatitis	0.000161	0.000667	CcSEcCtD
Cisplatin—Eye disorder—Betamethasone—atopic dermatitis	0.000161	0.000667	CcSEcCtD
Cisplatin—GSTT1—Metabolism—GLB1—atopic dermatitis	0.000161	0.00265	CbGpPWpGaD
Cisplatin—Malaise—Hydrocortisone—atopic dermatitis	0.000159	0.000656	CcSEcCtD
Cisplatin—MPO—Folate Metabolism—TNF—atopic dermatitis	0.000158	0.0026	CbGpPWpGaD
Cisplatin—Diarrhoea—Tacrolimus—atopic dermatitis	0.000157	0.000651	CcSEcCtD
Cisplatin—MPO—Vitamin B12 Metabolism—IL6—atopic dermatitis	0.000157	0.00258	CbGpPWpGaD
Cisplatin—Convulsion—Prednisolone—atopic dermatitis	0.000156	0.000645	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000155	0.00255	CbGpPWpGaD
Cisplatin—Arrhythmia—Betamethasone—atopic dermatitis	0.000154	0.000637	CcSEcCtD
Cisplatin—Arrhythmia—Dexamethasone—atopic dermatitis	0.000154	0.000637	CcSEcCtD
Cisplatin—GSTT1—Metabolism—ADSL—atopic dermatitis	0.000154	0.00254	CbGpPWpGaD
Cisplatin—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000154	0.000635	CcSEcCtD
Cisplatin—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000153	0.000634	CcSEcCtD
Cisplatin—Bradycardia—Prednisone—atopic dermatitis	0.000153	0.000633	CcSEcCtD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—atopic dermatitis	0.000153	0.00252	CbGpPWpGaD
Cisplatin—Alopecia—Betamethasone—atopic dermatitis	0.000152	0.00063	CcSEcCtD
Cisplatin—Alopecia—Dexamethasone—atopic dermatitis	0.000152	0.00063	CcSEcCtD
Cisplatin—Convulsion—Hydrocortisone—atopic dermatitis	0.000152	0.00063	CcSEcCtD
Cisplatin—Discomfort—Prednisolone—atopic dermatitis	0.000151	0.000626	CcSEcCtD
Cisplatin—XDH—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000151	0.00249	CbGpPWpGaD
Cisplatin—Erythema—Betamethasone—atopic dermatitis	0.00015	0.000621	CcSEcCtD
Cisplatin—Erythema—Dexamethasone—atopic dermatitis	0.00015	0.000621	CcSEcCtD
Cisplatin—Myalgia—Hydrocortisone—atopic dermatitis	0.00015	0.000619	CcSEcCtD
Cisplatin—Malaise—Triamcinolone—atopic dermatitis	0.000149	0.000617	CcSEcCtD
Cisplatin—Anxiety—Hydrocortisone—atopic dermatitis	0.000149	0.000617	CcSEcCtD
Cisplatin—Malaise—Methylprednisolone—atopic dermatitis	0.000149	0.000616	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000149	0.000615	CcSEcCtD
Cisplatin—Discomfort—Hydrocortisone—atopic dermatitis	0.000148	0.000611	CcSEcCtD
Cisplatin—Connective tissue disorder—Prednisone—atopic dermatitis	0.000148	0.000611	CcSEcCtD
Cisplatin—Oedema—Prednisolone—atopic dermatitis	0.000147	0.000607	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000147	0.000607	CcSEcCtD
Cisplatin—Vomiting—Tacrolimus—atopic dermatitis	0.000146	0.000605	CcSEcCtD
Cisplatin—ABCG2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000146	0.00241	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—IL6—atopic dermatitis	0.000146	0.00241	CbGpPWpGaD
Cisplatin—MT2A—Immune System—STAT6—atopic dermatitis	0.000145	0.00239	CbGpPWpGaD
Cisplatin—Rash—Tacrolimus—atopic dermatitis	0.000145	0.0006	CcSEcCtD
Cisplatin—Dermatitis—Tacrolimus—atopic dermatitis	0.000145	0.000599	CcSEcCtD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000145	0.00238	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—TNF—atopic dermatitis	0.000144	0.00237	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000144	0.00237	CbGpPWpGaD
Cisplatin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000143	0.000593	CcSEcCtD
Cisplatin—Oedema—Hydrocortisone—atopic dermatitis	0.000143	0.000593	CcSEcCtD
Cisplatin—Convulsion—Triamcinolone—atopic dermatitis	0.000143	0.000593	CcSEcCtD
Cisplatin—Tachycardia—Prednisolone—atopic dermatitis	0.000143	0.000593	CcSEcCtD
Cisplatin—Convulsion—Methylprednisolone—atopic dermatitis	0.000143	0.000592	CcSEcCtD
Cisplatin—Infection—Hydrocortisone—atopic dermatitis	0.000143	0.000589	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—CXCL8—atopic dermatitis	0.000142	0.00235	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000142	0.000587	CcSEcCtD
Cisplatin—MT2A—Immune System—CARD11—atopic dermatitis	0.000141	0.00233	CbGpPWpGaD
Cisplatin—Myalgia—Triamcinolone—atopic dermatitis	0.000141	0.000583	CcSEcCtD
Cisplatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000141	0.00232	CbGpPWpGaD
Cisplatin—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000141	0.000582	CcSEcCtD
Cisplatin—Myalgia—Methylprednisolone—atopic dermatitis	0.000141	0.000581	CcSEcCtD
Cisplatin—Eye disorder—Prednisone—atopic dermatitis	0.00014	0.000581	CcSEcCtD
Cisplatin—Anxiety—Methylprednisolone—atopic dermatitis	0.00014	0.000579	CcSEcCtD
Cisplatin—Tachycardia—Hydrocortisone—atopic dermatitis	0.00014	0.000579	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.00014	0.000577	CcSEcCtD
Cisplatin—Flushing—Prednisone—atopic dermatitis	0.000139	0.000577	CcSEcCtD
Cisplatin—Skin disorder—Hydrocortisone—atopic dermatitis	0.000139	0.000576	CcSEcCtD
Cisplatin—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000139	0.000576	CcSEcCtD
Cisplatin—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000139	0.000576	CcSEcCtD
Cisplatin—Discomfort—Triamcinolone—atopic dermatitis	0.000139	0.000576	CcSEcCtD
Cisplatin—Discomfort—Methylprednisolone—atopic dermatitis	0.000139	0.000574	CcSEcCtD
Cisplatin—PTGS2—Overview of nanoparticle effects—TNF—atopic dermatitis	0.000139	0.00229	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000139	0.000574	CcSEcCtD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IFNG—atopic dermatitis	0.000137	0.00226	CbGpPWpGaD
Cisplatin—Anorexia—Hydrocortisone—atopic dermatitis	0.000137	0.000566	CcSEcCtD
Cisplatin—Nausea—Tacrolimus—atopic dermatitis	0.000137	0.000565	CcSEcCtD
Cisplatin—ATP7B—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000137	0.00225	CbGpPWpGaD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—atopic dermatitis	0.000136	0.00224	CbGpPWpGaD
Cisplatin—Immune system disorder—Prednisone—atopic dermatitis	0.000136	0.000561	CcSEcCtD
Cisplatin—Malaise—Dexamethasone—atopic dermatitis	0.000135	0.00056	CcSEcCtD
Cisplatin—Malaise—Betamethasone—atopic dermatitis	0.000135	0.00056	CcSEcCtD
Cisplatin—Oedema—Triamcinolone—atopic dermatitis	0.000135	0.000559	CcSEcCtD
Cisplatin—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000135	0.000559	CcSEcCtD
Cisplatin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000135	0.000557	CcSEcCtD
Cisplatin—Arrhythmia—Prednisone—atopic dermatitis	0.000134	0.000555	CcSEcCtD
Cisplatin—Infection—Triamcinolone—atopic dermatitis	0.000134	0.000555	CcSEcCtD
Cisplatin—Hypotension—Hydrocortisone—atopic dermatitis	0.000134	0.000554	CcSEcCtD
Cisplatin—Infection—Methylprednisolone—atopic dermatitis	0.000134	0.000554	CcSEcCtD
Cisplatin—Alopecia—Prednisone—atopic dermatitis	0.000133	0.000549	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—IL13—atopic dermatitis	0.000132	0.00218	CbGpPWpGaD
Cisplatin—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000132	0.000547	CcSEcCtD
Cisplatin—Paraesthesia—Prednisolone—atopic dermatitis	0.000132	0.000545	CcSEcCtD
Cisplatin—Tachycardia—Triamcinolone—atopic dermatitis	0.000132	0.000545	CcSEcCtD
Cisplatin—Tachycardia—Methylprednisolone—atopic dermatitis	0.000132	0.000544	CcSEcCtD
Cisplatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000132	0.00217	CbGpPWpGaD
Cisplatin—Skin disorder—Methylprednisolone—atopic dermatitis	0.000131	0.000541	CcSEcCtD
Cisplatin—Erythema—Prednisone—atopic dermatitis	0.000131	0.000541	CcSEcCtD
Cisplatin—Malnutrition—Prednisone—atopic dermatitis	0.000131	0.000541	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000131	0.000541	CcSEcCtD
Cisplatin—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000131	0.00054	CcSEcCtD
Cisplatin—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.00013	0.000539	CcSEcCtD
Cisplatin—Convulsion—Betamethasone—atopic dermatitis	0.00013	0.000538	CcSEcCtD
Cisplatin—Convulsion—Dexamethasone—atopic dermatitis	0.00013	0.000538	CcSEcCtD
Cisplatin—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000129	0.000533	CcSEcCtD
Cisplatin—Myalgia—Dexamethasone—atopic dermatitis	0.000128	0.000529	CcSEcCtD
Cisplatin—Myalgia—Betamethasone—atopic dermatitis	0.000128	0.000529	CcSEcCtD
Cisplatin—Anxiety—Dexamethasone—atopic dermatitis	0.000127	0.000527	CcSEcCtD
Cisplatin—Anxiety—Betamethasone—atopic dermatitis	0.000127	0.000527	CcSEcCtD
Cisplatin—SOD1—Hemostasis—IL5—atopic dermatitis	0.000127	0.0021	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—IL6—atopic dermatitis	0.000127	0.0021	CbGpPWpGaD
Cisplatin—Discomfort—Betamethasone—atopic dermatitis	0.000126	0.000522	CcSEcCtD
Cisplatin—Discomfort—Dexamethasone—atopic dermatitis	0.000126	0.000522	CcSEcCtD
Cisplatin—Hypotension—Methylprednisolone—atopic dermatitis	0.000126	0.000521	CcSEcCtD
Cisplatin—Pain—Prednisolone—atopic dermatitis	0.000126	0.000519	CcSEcCtD
Cisplatin—MPO—Selenium Micronutrient Network—TNF—atopic dermatitis	0.000125	0.00207	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—MAPK8—atopic dermatitis	0.000125	0.00206	CbGpPWpGaD
Cisplatin—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000125	0.000516	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000124	0.000512	CcSEcCtD
Cisplatin—Vision blurred—Prednisone—atopic dermatitis	0.000123	0.00051	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000123	0.000509	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000123	0.000508	CcSEcCtD
Cisplatin—Pain—Hydrocortisone—atopic dermatitis	0.000123	0.000507	CcSEcCtD
Cisplatin—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000123	0.000507	CcSEcCtD
Cisplatin—Oedema—Betamethasone—atopic dermatitis	0.000123	0.000507	CcSEcCtD
Cisplatin—Oedema—Dexamethasone—atopic dermatitis	0.000123	0.000507	CcSEcCtD
Cisplatin—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000123	0.000507	CcSEcCtD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	0.000123	0.00202	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000122	0.00201	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL2—atopic dermatitis	0.000122	0.00201	CbGpPWpGaD
Cisplatin—Infection—Dexamethasone—atopic dermatitis	0.000122	0.000504	CcSEcCtD
Cisplatin—Infection—Betamethasone—atopic dermatitis	0.000122	0.000504	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	0.000122	0.002	CbGpPWpGaD
Cisplatin—Ill-defined disorder—Prednisone—atopic dermatitis	0.000121	0.000502	CcSEcCtD
Cisplatin—Paraesthesia—Triamcinolone—atopic dermatitis	0.000121	0.000502	CcSEcCtD
Cisplatin—Feeling abnormal—Prednisolone—atopic dermatitis	0.000121	0.000501	CcSEcCtD
Cisplatin—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000121	0.000501	CcSEcCtD
Cisplatin—Anaemia—Prednisone—atopic dermatitis	0.000121	0.0005	CcSEcCtD
Cisplatin—Dyspnoea—Triamcinolone—atopic dermatitis	0.00012	0.000498	CcSEcCtD
Cisplatin—Nervous system disorder—Betamethasone—atopic dermatitis	0.00012	0.000497	CcSEcCtD
Cisplatin—Nervous system disorder—Dexamethasone—atopic dermatitis	0.00012	0.000497	CcSEcCtD
Cisplatin—Thrombocytopenia—Betamethasone—atopic dermatitis	0.00012	0.000496	CcSEcCtD
Cisplatin—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.00012	0.000496	CcSEcCtD
Cisplatin—Tachycardia—Betamethasone—atopic dermatitis	0.00012	0.000495	CcSEcCtD
Cisplatin—Tachycardia—Dexamethasone—atopic dermatitis	0.00012	0.000495	CcSEcCtD
Cisplatin—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000119	0.00049	CcSEcCtD
Cisplatin—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000119	0.00049	CcSEcCtD
Cisplatin—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000118	0.000489	CcSEcCtD
Cisplatin—Malaise—Prednisone—atopic dermatitis	0.000118	0.000488	CcSEcCtD
Cisplatin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.000117	0.00193	CbGpPWpGaD
Cisplatin—Anorexia—Dexamethasone—atopic dermatitis	0.000117	0.000483	CcSEcCtD
Cisplatin—Anorexia—Betamethasone—atopic dermatitis	0.000117	0.000483	CcSEcCtD
Cisplatin—ATP7A—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000116	0.00191	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—IL6—atopic dermatitis	0.000116	0.00191	CbGpPWpGaD
Cisplatin—Pain—Triamcinolone—atopic dermatitis	0.000116	0.000478	CcSEcCtD
Cisplatin—Hypotension—Betamethasone—atopic dermatitis	0.000115	0.000474	CcSEcCtD
Cisplatin—Hypotension—Dexamethasone—atopic dermatitis	0.000115	0.000474	CcSEcCtD
Cisplatin—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000113	0.000469	CcSEcCtD
Cisplatin—Convulsion—Prednisone—atopic dermatitis	0.000113	0.000469	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—IL5—atopic dermatitis	0.000113	0.00186	CbGpPWpGaD
Cisplatin—PTGS2—Overview of nanoparticle effects—IL6—atopic dermatitis	0.000112	0.00185	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000112	0.000462	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000112	0.000462	CcSEcCtD
Cisplatin—Myalgia—Prednisone—atopic dermatitis	0.000111	0.00046	CcSEcCtD
Cisplatin—ABCC6—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000111	0.00183	CbGpPWpGaD
Cisplatin—SLC31A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000111	0.00183	CbGpPWpGaD
Cisplatin—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000111	0.00046	CcSEcCtD
Cisplatin—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000111	0.000459	CcSEcCtD
Cisplatin—Anxiety—Prednisone—atopic dermatitis	0.000111	0.000459	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000111	0.000457	CcSEcCtD
Cisplatin—Paraesthesia—Betamethasone—atopic dermatitis	0.00011	0.000455	CcSEcCtD
Cisplatin—Paraesthesia—Dexamethasone—atopic dermatitis	0.00011	0.000455	CcSEcCtD
Cisplatin—MT2A—Immune System—CASP1—atopic dermatitis	0.00011	0.00181	CbGpPWpGaD
Cisplatin—Discomfort—Prednisone—atopic dermatitis	0.00011	0.000455	CcSEcCtD
Cisplatin—XDH—Selenium Micronutrient Network—TNF—atopic dermatitis	0.00011	0.00181	CbGpPWpGaD
Cisplatin—Hypersensitivity—Prednisolone—atopic dermatitis	0.000108	0.000448	CcSEcCtD
Cisplatin—Body temperature increased—Triamcinolone—atopic dermatitis	0.000107	0.000442	CcSEcCtD
Cisplatin—Oedema—Prednisone—atopic dermatitis	0.000107	0.000441	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisone—atopic dermatitis	0.000107	0.000441	CcSEcCtD
Cisplatin—Decreased appetite—Betamethasone—atopic dermatitis	0.000107	0.000441	CcSEcCtD
Cisplatin—Decreased appetite—Dexamethasone—atopic dermatitis	0.000107	0.000441	CcSEcCtD
Cisplatin—Infection—Prednisone—atopic dermatitis	0.000106	0.000439	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000106	0.000438	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000106	0.000438	CcSEcCtD
Cisplatin—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000106	0.000437	CcSEcCtD
Cisplatin—ABCC5—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000106	0.00174	CbGpPWpGaD
Cisplatin—Pain—Betamethasone—atopic dermatitis	0.000105	0.000433	CcSEcCtD
Cisplatin—Pain—Dexamethasone—atopic dermatitis	0.000105	0.000433	CcSEcCtD
Cisplatin—Nervous system disorder—Prednisone—atopic dermatitis	0.000105	0.000433	CcSEcCtD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000104	0.00172	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL5—atopic dermatitis	0.000104	0.00172	CbGpPWpGaD
Cisplatin—Tachycardia—Prednisone—atopic dermatitis	0.000104	0.000431	CcSEcCtD
Cisplatin—Skin disorder—Prednisone—atopic dermatitis	0.000104	0.000429	CcSEcCtD
Cisplatin—GSTM1—Metabolism—GLB1—atopic dermatitis	0.000104	0.00171	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Prednisone—atopic dermatitis	0.000103	0.000427	CcSEcCtD
Cisplatin—Asthenia—Hydrocortisone—atopic dermatitis	0.000103	0.000426	CcSEcCtD
Cisplatin—Anorexia—Prednisone—atopic dermatitis	0.000102	0.000421	CcSEcCtD
Cisplatin—MPO—Selenium Micronutrient Network—IL6—atopic dermatitis	0.000101	0.00167	CbGpPWpGaD
Cisplatin—Feeling abnormal—Betamethasone—atopic dermatitis	0.000101	0.000418	CcSEcCtD
Cisplatin—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000101	0.000418	CcSEcCtD
Cisplatin—MT2A—Immune System—TLR2—atopic dermatitis	9.96e-05	0.00164	CbGpPWpGaD
Cisplatin—Hypersensitivity—Triamcinolone—atopic dermatitis	9.95e-05	0.000412	CcSEcCtD
Cisplatin—Hypersensitivity—Methylprednisolone—atopic dermatitis	9.93e-05	0.000411	CcSEcCtD
Cisplatin—GSTM1—Metabolism—ADSL—atopic dermatitis	9.93e-05	0.00164	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—atopic dermatitis	9.89e-05	0.00163	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CXCL10—atopic dermatitis	9.87e-05	0.00163	CbGpPWpGaD
Cisplatin—Diarrhoea—Hydrocortisone—atopic dermatitis	9.82e-05	0.000406	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	9.73e-05	0.000402	CcSEcCtD
Cisplatin—Asthenia—Triamcinolone—atopic dermatitis	9.69e-05	0.000401	CcSEcCtD
Cisplatin—Body temperature increased—Dexamethasone—atopic dermatitis	9.69e-05	0.000401	CcSEcCtD
Cisplatin—Body temperature increased—Betamethasone—atopic dermatitis	9.69e-05	0.000401	CcSEcCtD
Cisplatin—Asthenia—Methylprednisolone—atopic dermatitis	9.67e-05	0.0004	CcSEcCtD
Cisplatin—Paraesthesia—Prednisone—atopic dermatitis	9.59e-05	0.000396	CcSEcCtD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	9.45e-05	0.00156	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD79A—atopic dermatitis	9.36e-05	0.00154	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	9.33e-05	0.00154	CbGpPWpGaD
Cisplatin—Decreased appetite—Prednisone—atopic dermatitis	9.28e-05	0.000384	CcSEcCtD
Cisplatin—Rash—Prednisolone—atopic dermatitis	9.26e-05	0.000383	CcSEcCtD
Cisplatin—Dermatitis—Prednisolone—atopic dermatitis	9.26e-05	0.000383	CcSEcCtD
Cisplatin—Diarrhoea—Methylprednisolone—atopic dermatitis	9.22e-05	0.000381	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atopic dermatitis	9.2e-05	0.00152	CbGpPWpGaD
Cisplatin—Vomiting—Hydrocortisone—atopic dermatitis	9.12e-05	0.000377	CcSEcCtD
Cisplatin—Rash—Hydrocortisone—atopic dermatitis	9.05e-05	0.000374	CcSEcCtD
Cisplatin—Dermatitis—Hydrocortisone—atopic dermatitis	9.04e-05	0.000374	CcSEcCtD
Cisplatin—PTGS2—Spinal Cord Injury—BDNF—atopic dermatitis	8.87e-05	0.00146	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—IL6—atopic dermatitis	8.85e-05	0.00146	CbGpPWpGaD
Cisplatin—ABCC5—Disease—GLB1—atopic dermatitis	8.81e-05	0.00145	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GLB1—atopic dermatitis	8.81e-05	0.00145	CbGpPWpGaD
Cisplatin—Feeling abnormal—Prednisone—atopic dermatitis	8.8e-05	0.000364	CcSEcCtD
Cisplatin—Asthenia—Betamethasone—atopic dermatitis	8.8e-05	0.000364	CcSEcCtD
Cisplatin—Asthenia—Dexamethasone—atopic dermatitis	8.8e-05	0.000364	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—atopic dermatitis	8.79e-05	0.00145	CbGpPWpGaD
Cisplatin—Nausea—Prednisolone—atopic dermatitis	8.73e-05	0.000361	CcSEcCtD
Cisplatin—Vomiting—Triamcinolone—atopic dermatitis	8.59e-05	0.000355	CcSEcCtD
Cisplatin—NQO1—Metabolism—GLB1—atopic dermatitis	8.58e-05	0.00141	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—CXCL8—atopic dermatitis	8.57e-05	0.00141	CbGpPWpGaD
Cisplatin—Vomiting—Methylprednisolone—atopic dermatitis	8.57e-05	0.000354	CcSEcCtD
Cisplatin—Nausea—Hydrocortisone—atopic dermatitis	8.52e-05	0.000352	CcSEcCtD
Cisplatin—Rash—Triamcinolone—atopic dermatitis	8.52e-05	0.000352	CcSEcCtD
Cisplatin—Dermatitis—Triamcinolone—atopic dermatitis	8.51e-05	0.000352	CcSEcCtD
Cisplatin—Rash—Methylprednisolone—atopic dermatitis	8.5e-05	0.000351	CcSEcCtD
Cisplatin—Dermatitis—Methylprednisolone—atopic dermatitis	8.49e-05	0.000351	CcSEcCtD
Cisplatin—GSTP1—Metabolism—ADSL—atopic dermatitis	8.44e-05	0.00139	CbGpPWpGaD
Cisplatin—Body temperature increased—Prednisone—atopic dermatitis	8.44e-05	0.000349	CcSEcCtD
Cisplatin—Diarrhoea—Dexamethasone—atopic dermatitis	8.39e-05	0.000347	CcSEcCtD
Cisplatin—Diarrhoea—Betamethasone—atopic dermatitis	8.39e-05	0.000347	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—IL10—atopic dermatitis	8.27e-05	0.00136	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL4—atopic dermatitis	8.23e-05	0.00136	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ADSL—atopic dermatitis	8.23e-05	0.00136	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—GLB1—atopic dermatitis	8.07e-05	0.00133	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL4—atopic dermatitis	8.05e-05	0.00133	CbGpPWpGaD
Cisplatin—Nausea—Triamcinolone—atopic dermatitis	8.03e-05	0.000332	CcSEcCtD
Cisplatin—Nausea—Methylprednisolone—atopic dermatitis	8.01e-05	0.000331	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—IL6—atopic dermatitis	8e-05	0.00132	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	7.9e-05	0.0013	CbGpPWpGaD
Cisplatin—Hypersensitivity—Prednisone—atopic dermatitis	7.87e-05	0.000325	CcSEcCtD
Cisplatin—Vomiting—Dexamethasone—atopic dermatitis	7.79e-05	0.000322	CcSEcCtD
Cisplatin—Vomiting—Betamethasone—atopic dermatitis	7.79e-05	0.000322	CcSEcCtD
Cisplatin—ABCC3—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	7.78e-05	0.00128	CbGpPWpGaD
Cisplatin—Rash—Dexamethasone—atopic dermatitis	7.73e-05	0.00032	CcSEcCtD
Cisplatin—Rash—Betamethasone—atopic dermatitis	7.73e-05	0.00032	CcSEcCtD
Cisplatin—Dermatitis—Dexamethasone—atopic dermatitis	7.72e-05	0.000319	CcSEcCtD
Cisplatin—Dermatitis—Betamethasone—atopic dermatitis	7.72e-05	0.000319	CcSEcCtD
Cisplatin—XDH—Metabolism—GLB1—atopic dermatitis	7.7e-05	0.00127	CbGpPWpGaD
Cisplatin—Asthenia—Prednisone—atopic dermatitis	7.66e-05	0.000317	CcSEcCtD
Cisplatin—MT2A—Immune System—IL18—atopic dermatitis	7.66e-05	0.00126	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD8A—atopic dermatitis	7.54e-05	0.00124	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—MAPK8—atopic dermatitis	7.54e-05	0.00124	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CXCL8—atopic dermatitis	7.48e-05	0.00123	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GLB1—atopic dermatitis	7.38e-05	0.00122	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ADSL—atopic dermatitis	7.38e-05	0.00122	CbGpPWpGaD
Cisplatin—Diarrhoea—Prednisone—atopic dermatitis	7.3e-05	0.000302	CcSEcCtD
Cisplatin—Nausea—Dexamethasone—atopic dermatitis	7.28e-05	0.000301	CcSEcCtD
Cisplatin—Nausea—Betamethasone—atopic dermatitis	7.28e-05	0.000301	CcSEcCtD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL6—atopic dermatitis	7.18e-05	0.00118	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ADSL—atopic dermatitis	7.08e-05	0.00117	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	6.85e-05	0.00113	CbGpPWpGaD
Cisplatin—Vomiting—Prednisone—atopic dermatitis	6.79e-05	0.000281	CcSEcCtD
Cisplatin—Rash—Prednisone—atopic dermatitis	6.73e-05	0.000278	CcSEcCtD
Cisplatin—Dermatitis—Prednisone—atopic dermatitis	6.73e-05	0.000278	CcSEcCtD
Cisplatin—GSTP1—Cellular responses to stress—MAPK8—atopic dermatitis	6.58e-05	0.00108	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.42e-05	0.00106	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atopic dermatitis	6.4e-05	0.00106	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GLB1—atopic dermatitis	6.4e-05	0.00105	CbGpPWpGaD
Cisplatin—Nausea—Prednisone—atopic dermatitis	6.34e-05	0.000262	CcSEcCtD
Cisplatin—PTGS2—C-MYB transcription factor network—CD4—atopic dermatitis	6.31e-05	0.00104	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IFNG—atopic dermatitis	6.29e-05	0.00104	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	6.17e-05	0.00102	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ADSL—atopic dermatitis	6.13e-05	0.00101	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CMA1—atopic dermatitis	6.11e-05	0.00101	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	6.03e-05	0.000994	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SLC11A1—atopic dermatitis	5.9e-05	0.000973	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NFKBIA—atopic dermatitis	5.85e-05	0.000964	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	5.72e-05	0.000943	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IL1B—atopic dermatitis	5.61e-05	0.000925	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GLB1—atopic dermatitis	5.44e-05	0.000896	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	5.37e-05	0.000884	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	5.31e-05	0.000875	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CASP8—atopic dermatitis	5.28e-05	0.000869	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PPARA—atopic dermatitis	5.22e-05	0.000859	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ADSL—atopic dermatitis	5.22e-05	0.000859	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.11e-05	0.000842	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IFNG—atopic dermatitis	4.98e-05	0.00082	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—IL2—atopic dermatitis	4.87e-05	0.000802	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	4.86e-05	0.000801	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—IL6—atopic dermatitis	4.82e-05	0.000793	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.66e-05	0.000768	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CXCL8—atopic dermatitis	4.63e-05	0.000763	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	4.52e-05	0.000745	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IFNG—atopic dermatitis	4.49e-05	0.000739	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL1B—atopic dermatitis	4.44e-05	0.000732	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL2—atopic dermatitis	4.42e-05	0.000729	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	4.42e-05	0.000727	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	4.34e-05	0.000715	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD4—atopic dermatitis	4.33e-05	0.000714	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL2—atopic dermatitis	4.32e-05	0.000712	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.28e-05	0.000704	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.25e-05	0.000701	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—IL6—atopic dermatitis	4.2e-05	0.000692	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GLB1—atopic dermatitis	4.16e-05	0.000685	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—TNF—atopic dermatitis	4.07e-05	0.000671	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL1B—atopic dermatitis	4e-05	0.000659	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL2—atopic dermatitis	3.99e-05	0.000657	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ADSL—atopic dermatitis	3.99e-05	0.000657	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.98e-05	0.000656	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.96e-05	0.000653	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.77e-05	0.000621	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GLB1—atopic dermatitis	3.75e-05	0.000618	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GLB1—atopic dermatitis	3.71e-05	0.000612	CbGpPWpGaD
Cisplatin—MT2A—Immune System—MAPK8—atopic dermatitis	3.67e-05	0.000605	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ADSL—atopic dermatitis	3.6e-05	0.000593	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ADSL—atopic dermatitis	3.56e-05	0.000586	CbGpPWpGaD
Cisplatin—PTGS2—Disease—GLB1—atopic dermatitis	3.42e-05	0.000563	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PPARA—atopic dermatitis	3.36e-05	0.000554	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IL6—atopic dermatitis	3.29e-05	0.000542	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TNF—atopic dermatitis	3.22e-05	0.000531	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TNF—atopic dermatitis	3.15e-05	0.000519	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.13e-05	0.000516	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.03e-05	0.000499	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.99e-05	0.000492	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CCR5—atopic dermatitis	2.98e-05	0.000491	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.9e-05	0.000478	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GLB1—atopic dermatitis	2.86e-05	0.000471	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PPARA—atopic dermatitis	2.86e-05	0.000471	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.82e-05	0.000465	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PPARA—atopic dermatitis	2.79e-05	0.000459	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.77e-05	0.000456	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GLB1—atopic dermatitis	2.75e-05	0.000453	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ADSL—atopic dermatitis	2.74e-05	0.000452	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ADSL—atopic dermatitis	2.64e-05	0.000434	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL6—atopic dermatitis	2.6e-05	0.000428	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.6e-05	0.000428	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.57e-05	0.000424	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PPARA—atopic dermatitis	2.5e-05	0.000412	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PPARA—atopic dermatitis	2.4e-05	0.000395	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL6—atopic dermatitis	2.34e-05	0.000386	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SLC11A1—atopic dermatitis	2.29e-05	0.000377	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.19e-05	0.000361	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.08e-05	0.000344	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PPARA—atopic dermatitis	2.08e-05	0.000342	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GLB1—atopic dermatitis	2.03e-05	0.000334	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.96e-05	0.000323	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ADSL—atopic dermatitis	1.94e-05	0.00032	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GLB1—atopic dermatitis	1.89e-05	0.000312	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CD4—atopic dermatitis	1.87e-05	0.000309	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ADSL—atopic dermatitis	1.82e-05	0.000299	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PPARA—atopic dermatitis	1.77e-05	0.000291	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CXCL8—atopic dermatitis	1.65e-05	0.000272	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.55e-05	0.000256	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.41e-05	0.000232	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.38e-05	0.000227	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPARA—atopic dermatitis	1.35e-05	0.000222	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARA—atopic dermatitis	1.22e-05	0.000201	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARA—atopic dermatitis	1.2e-05	0.000199	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CCR5—atopic dermatitis	1.16e-05	0.000191	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—atopic dermatitis	1.01e-05	0.000167	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARA—atopic dermatitis	9.29e-06	0.000153	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARA—atopic dermatitis	8.92e-06	0.000147	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD4—atopic dermatitis	7.26e-06	0.00012	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARA—atopic dermatitis	6.58e-06	0.000108	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARA—atopic dermatitis	6.15e-06	0.000101	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—atopic dermatitis	3.93e-06	6.47e-05	CbGpPWpGaD
